Life Care News
A Hope Of True Information

- Advertisement -

Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan


STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) — Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland, President and Chief Executive Officer, will deliver a formal presentation on Thursday, January 12, 2023, at 10:30 a.m. PT.

A live and archived webcast of the presentation will be available on the “Events” section of the Sema4|GeneDx investor relations website at

About Sema4|GeneDx

Sema4|GeneDx is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Tricia Truehart
Investor Relations

Get real time updates directly on you device, subscribe now.

Has Aji River now become a dumping site?